Papers
7
Total Citations
92
H-Index
6
About
Khaled Ajib is a urologic oncology researcher whose work centers on improving outcomes for men with localized prostate cancer, particularly through the refinement of robot-assisted radical prostatectomy (RARP). His most impactful research investigates the prognostic value of inflammatory biomarkers, demonstrating that the neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) can help predict biochemical recurrence following robotic prostatectomy—a finding with over 50 combined citations that offers clinicians a simple, cost-effective tool for risk stratification. Ajib has also made significant contributions to understanding surgical complications and recovery, including landmark studies on risk factors for acute urinary retention after RARP and its relationship with early continence, as well as the use of augmented reality devices like the AccuVein AV400 to reduce abdominal wall hematomas. Drawing from a large Canadian database spanning a decade of surgical experience, his work has provided crucial real-world evidence on both oncological and functional outcomes in a healthcare system with limited robotic access. Ajib’s research bridges the gap between surgical innovation and practical patient care, offering evidence-based insights that help surgeons optimize recovery pathways and improve quality of life for prostate cancer patients.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6
- 7Single-night stay for open radical prostatectomy2 citations · 2020